JLL Research Report: Life Sciences Outlook (2018)
Life Sciences innovation is evolving at a breathtaking pace. Shifting priorities are creating new models, the race for talent is quickening and emerging markets are providing more value than ever before.
JLL takes an annual look at the evolution of the top geographies across the U.S., and Boston and San Francisco maintained their leadership despite high rents and low availability.
Some of the most dynamic changes were seen in the mid-tier clusters that includes Denver, Seattle, suburban Maryland, New Jersey, and Westchester (NY). As Life Sciences companies enter a new era of collaborative research and development, flexibility, and need for more creative space, an effective real estate and facilities strategy is key.